Michael H Kagey

2PUBLICATIONS
13CO-AUTHORS
ChemotherapyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jul 23, 2026
Sirexatamab in Combination with Bevacizumab and Chemotherapy as Second-Line Therapy for Advanced Colorectal Adenocarcinoma: the Phase II DeFianCe Trial.

|Jun 03, 2017
Rationale for targeting the Wnt signalling modulator Dickkopf-1 for oncology.

Michael H Kagey, Xi He

Pageof 1

Frequent Collaborators

1 joint publications

Zev A Wainberg

1 joint publications

Keun-Wook Lee

1 joint publications

Jong Gwang Kim

1 joint publications

Craig Devoe